Sapien Valve-in-Valve Approved by FDA

ACC Conference Reporter

TCT 2015 | SAN FRANCISCO — The FDA approved the Sapien XT aortic valve to replace failing bioprostheses in high surgical risk patients, a move based on good 1-year survival and safety results reported here from the PARTNER II valve-in-valve registry. Read More >>>

Keywords: Transcatheter Cardiovascular Therapeutics

< Back to Listings